Shoulder Innovations (NYSE:SI) COO Matthew Fraser Ahearn Sells 14,186 Shares

Shoulder Innovations, Inc. (NYSE:SI) COO Matthew Fraser Ahearn sold 14,186 shares of Shoulder Innovations stock in a transaction that occurred on Tuesday, August 18th. The shares were sold at an average price of $20.99, for a total value of $297,764.14. Following the completion of the transaction, the chief operating officer owned 244,176 shares in the company, valued at $5,125,254.24. This trade represents a 5.49% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Matthew Fraser Ahearn also recently made the following trade(s):

• On Monday, August 17th, Matthew Fraser Ahearn sold 8,314 shares of Shoulder Innovations stock. The stock was sold at an average price of $20.10, for a total value of $167,111.40.
• On Monday, June 15th, Matthew Fraser Ahearn sold 4,144 shares of Shoulder Innovations stock. The stock was sold at an average price of $18.84, for a total value of $78,072.96.
• On Friday, June 12th, Matthew Fraser Ahearn sold 15,856 shares of Shoulder Innovations stock. The shares were sold at an average price of $18.68, for a total transaction of $296,190.08.

Shoulder Innovations Stock Up 5.9%

Shares of Shoulder Innovations stock opened at $21.09 on Wednesday. The company has a market cap of $439.16 million and a P/E ratio of -10.99. The company has a debt-to-equity ratio of 0.12, a quick ratio of 8.92 and a current ratio of 10.71. Shoulder Innovations, Inc. has a one year low of $10.92 and a one year high of $24.59. The firm has a fifty day moving average of $20.72 and a two-hundred day moving average of $16.37.

Shoulder Innovations (NYSE:SI) last issued its earnings results on Thursday, August 6th. The company reported ($0.49) earnings per share for the quarter, missing the consensus estimate of ($0.46) by ($0.03). Shoulder Innovations had a negative net margin of 58.33% and a negative return on equity of 23.61%. The firm had revenue of $17.18 million during the quarter. On average, analysts forecast that Shoulder Innovations, Inc. will post -1.9 earnings per share for the current year.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of SI. Deerfield Management Company L.P. purchased a new stake in Shoulder Innovations during the third quarter worth approximately $6,056,000. Alyeska Investment Group L.P. acquired a new position in shares of Shoulder Innovations in the third quarter worth about $5,667,000. Vanguard Group Inc. purchased a new position in shares of Shoulder Innovations during the 3rd quarter valued at approximately $1,836,000. Roubaix Capital LLC boosted its stake in Shoulder Innovations by 61.9% during the 1st quarter. Roubaix Capital LLC now owns 257,121 shares of the company’s stock valued at $3,736,000 after acquiring an additional 98,305 shares during the last quarter. Finally, Millennium Management LLC acquired a new stake in shares of Shoulder Innovations in the 4th quarter valued at about $1,316,000.

Analyst Ratings Changes

A number of brokerages have recently issued reports on SI. Weiss Ratings raised Shoulder Innovations from a “sell (d-)” rating to a “sell (d)” rating in a research note on Monday, August 3rd. UBS Group lifted their price target on shares of Shoulder Innovations from $27.00 to $28.00 and gave the company a “buy” rating in a research report on Monday, August 10th. BTIG Research boosted their price target on Shoulder Innovations from $24.00 to $26.00 and gave the stock a “buy” rating in a research note on Friday, August 7th. Finally, Piper Sandler restated an “overweight” rating and issued a $25.00 price target (up from $19.00) on shares of Shoulder Innovations in a report on Friday, August 7th. Six analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $23.50.

Shoulder Innovations Company Profile

Shoulder Innovations (NYSE:SI) is a medical device company focused on the design, development and commercialization of shoulder implant systems and related surgical instruments for orthopedic surgery. The company’s product portfolio includes modular shoulder prostheses, humeral and glenoid components, and instrumentation kits designed to facilitate both primary and revision shoulder arthroplasty procedures. Emphasizing a patient-centric approach, Shoulder Innovations works to offer implant solutions that aim to restore mobility and reduce post-operative complications.

In addition to its core implant offerings, Shoulder Innovations provides comprehensive clinical support and training programs for surgeons and operating room teams.